BRAF and colorectal carcinoma: Clinically, BRAF p.V600E defines a biologically and prognostically distinct CRC subgroup: it is associated with aggressive behavior, a higher propensity for peritoneal and distant spread, and inferior overall survival compared with BRAF-wildtype disease, particularly in the metastatic setting.